COLLEGIUM PHARMACEUTICAL INC's ticker is and the CUSIP is 19459JAA2. A total of 15 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,292,660 | +2.0% | 3,244,000 | 0.0% | 0.00% | – |
| Q2 2023 | $3,227,780 | +37.2% | 3,244,000 | +45.9% | 0.00% | – |
| Q1 2023 | $2,351,880 | +7.4% | 2,224,000 | +2.3% | 0.00% | – |
| Q4 2022 | $2,189,653 | +18.2% | 2,174,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,852,000 | -3.3% | 2,174,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,916,000 | -27.9% | 2,174,000 | -18.7% | 0.00% | – |
| Q1 2022 | $2,659,000 | +3.1% | 2,674,000 | 0.0% | 0.00% | – |
| Q4 2021 | $2,578,000 | -3.0% | 2,674,000 | 0.0% | 0.00% | – |
| Q3 2021 | $2,657,000 | -33.1% | 2,674,000 | -27.2% | 0.00% | -100.0% |
| Q2 2021 | $3,972,000 | -0.7% | 3,674,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,001,000 | -8.3% | 3,674,000 | -17.5% | 0.00% | 0.0% |
| Q4 2020 | $4,365,000 | -19.4% | 4,454,000 | -18.2% | 0.00% | 0.0% |
| Q3 2020 | $5,414,000 | +115.2% | 5,444,000 | +95.1% | 0.00% | 0.0% |
| Q2 2020 | $2,516,000 | +130.0% | 2,791,000 | +132.6% | 0.00% | – |
| Q1 2020 | $1,094,000 | – | 1,200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 17,500,000 | $189,560,000 | 2.40% |
| STEELHEAD PARTNERS LLC | 21,000,000 | $22,877,000 | 1.73% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,245,000 | $33,292,000 | 1.33% |
| DeepCurrents Investment Group LLC | 8,900,000 | $9,745,000 | 0.34% |
| LINDEN ADVISORS LP | 28,000,000 | $30,455,000 | 0.23% |
| Teton Advisors, Inc. | 500,000 | $542,000 | 0.08% |
| Verition Fund Management LLC | 2,589,000 | $2,823,000 | 0.03% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 190,000 | $206,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 18,000,000 | $19,628,000 | 0.02% |
| GABELLI FUNDS LLC | 3,000,000 | $3,254,000 | 0.02% |